Philotimo Fund, LP 13D and 13G filings for Aytu BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-06-26 5:36 pm Purchase |
2025-06-06 | 13G | Aytu BioPharma, Inc. AYTU |
Philotimo Fund, LP | 573,358 6.400% |
407,090![]() (+244.84%) |
Filing |
2025-06-26 5:31 pm Sale |
2025-05-22 | 13G | Aytu BioPharma, Inc. AYTU |
Philotimo Fund, LP | 166,268 2.700% |
-468,805![]() (-73.82%) |
Filing |
2025-06-26 5:18 pm Purchase |
2025-05-15 | 13G | Aytu BioPharma, Inc. AYTU |
Philotimo Fund, LP | 635,073 10.300% |
253,268![]() (+66.33%) |
Filing |
2025-06-26 5:01 pm Purchase |
2025-05-14 | 13G | Aytu BioPharma, Inc. AYTU |
Philotimo Fund, LP | 381,805 6.200% |
381,805![]() (New Position) |
Filing |